comparemela.com

Page 5 - Phil Febbo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Illumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023

SAN DIEGO, May 31, 2023 /PRNewswire/ Illumina, Inc. announced today that it will host its third annual virtual Environment, Social and Corporate Governance focused investor event at 9:00 am. | May 31, 2023

Phil febboJohn frankSharon vidalAimee hoytJoydeep goswamiDavid mcalpineIllumina incCorporate developmentPrnewswire illumina incPublic affairsCorporate governancePacific timeEastern timeChief executive officerChief financial officerChief strategy

Illumina to Host Third Annual Virtual ESG Investor Event on Monday, June 12, 2023

/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN) announced today that it will host its third annual virtual Environment, Social and Corporate Governance (ESG).

John frankSharon vidalPhil febboAimee hoytJoydeep goswamiDavid mcalpinePublic affairsIllumina incPrnewswire illumina incCorporate developmentCorporate governancePacific timeEastern timeChief executive officerChief financial officerChief strategy

Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing

/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the.

New yorkUnited statesCarlo bifulcoPhil febboKevin keeganDavid mcalpineOncology informatics academic consortiumPrnewswire illumina incAmerican society of clinical oncology annual meetingIllumina incAllegheny health networkAmerican societyClinical oncologyAnnual meeting juneOncology informatics academicMedicare advantage

Illumina s genomic technologies enable better pathogen preparedness and response

/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of.

United statesAndrew gorzalskiVanessa moederPhil febboDavid mcalpineNevada state health labPan american health organizationDepartment of agricultureGlobal health at illuminaPathogen genomics initiativeNational institute of healthPrnewswire illumina incIllumina incUniversity of pittsburgh school medicineUs centers for diseaseDrug administration

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients

/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health.

United statesDavid lanfearPhil febboDavid mcalpineHenry fordIllumina incChristopher jeffries centerDrug administrationWorld health organizationGenomic medicine research at henry ford healthHenry ford healthAmerican college of medical geneticistsClinical pharmacogenetics implementation consortiumDivision of cardiovascular medicine at henry fordCardiovascular medicinePrecision medicine

vimarsana © 2020. All Rights Reserved.